06.02.4000 BetaCellTherapy: Official starting date

“BetaCellTherapy”, standing for ‘Beta Cell Programming for Treatment of Diabetes’, officially started in 2005 and it will last five years, until 2010, setting up a platform representing a network of teams in 19 institutions of eight European countries.

The R&D programme comprises three Project Areas, lead by a Project Leader, consisting of three or four Projects each, in which a coordinator organises the collaboration among associated teams and their principal investigators. The R&D platform drives the clinical trials and bio-industrial activities of the Juvenile Diabetes Research Foundation JDRF Center for the project. In addition to generating tools and strategies, it provides a scientific and technologic basis for working out new opportunities as well as for solving problems and obstacles encountered during implementation. It is also seen as a source of novel knowledge.